Dissecting the interaction between COVID-19 and diabetes mellitus

44Citations
Citations of this article
410Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Coronavirus disease 2019 (COVID-19) is a global pandemic that is caused by a novel coronavirus, severe acute respiratory syndrome coronavirus-2. Data from several countries have shown higher morbidity and mortality among individuals with chronic metabolic diseases, such as diabetes mellitus. In this review, we explore the contributing factors for poorer prognosis in these individuals. As a significant proportion of patients with COVID-19 also have diabetes mellitus, this adds another layer of complexity to their management. We explore potential interactions between antidiabetic medications and renin–angiotensin–aldosterone system inhibitors with COVID-19. Suggested recommendations for the use of antidiabetic medications for COVID-19 patients with diabetes mellitus are provided. We also review pertinent clinical considerations in the management of diabetic ketoacidosis in COVID-19 patients. In addition, we aim to increase clinicians’ awareness of the metabolic effects of promising drug therapies for COVID-19. Finally, we highlight the importance of timely vaccinations for patients with diabetes mellitus.

Author supplied keywords

Cite

CITATION STYLE

APA

Chee, Y. J., Tan, S. K., & Yeoh, E. (2020, September 1). Dissecting the interaction between COVID-19 and diabetes mellitus. Journal of Diabetes Investigation. Blackwell Publishing. https://doi.org/10.1111/jdi.13326

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free